Bryner v. E.I. Dupont De Nemours & Co.

914 F. Supp. 2d 755, 55 Employee Benefits Cas. (BNA) 1781, 2012 WL 6725634, 2012 U.S. Dist. LEXIS 182133
CourtDistrict Court, E.D. Virginia
DecidedDecember 27, 2012
DocketCivil Action No. 3:12CV103-HEH
StatusPublished
Cited by1 cases

This text of 914 F. Supp. 2d 755 (Bryner v. E.I. Dupont De Nemours & Co.) is published on Counsel Stack Legal Research, covering District Court, E.D. Virginia primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Bryner v. E.I. Dupont De Nemours & Co., 914 F. Supp. 2d 755, 55 Employee Benefits Cas. (BNA) 1781, 2012 WL 6725634, 2012 U.S. Dist. LEXIS 182133 (E.D. Va. 2012).

Opinion

MEMORANDUM OPINION

(Cross Motions for Summary Judgment)

HENRY E. HUDSON, District Judge.

Michael A. Bryner (“Bryner”) brought this action against his employer, E.I. du Pont de Nemours & Company (“DuPont”), under the Employee Retirement Income Security Act of 1974 (“ERISA”), 29 U.S.C. §§ 1001-1461, challenging its denial of accidental death benefits. Bryner’s claim arose from his wife’s death while under the care of her treating physician. The dispute turns on the definition of a “covered accident.” The parties have filed cross motions for summary judgment, which have been thoroughly briefed, and the Court has entertained oral argument. For the reasons that follow, the Court agrees that DuPont’s decision must be reviewed under the deferential “abuse of discretion” standard. However, DuPont’s analysis of the claim does not employ a reasonable definition of the term “accident,” and consequently it has abused its discretion in denying Bryner’s claim. Accordingly, the Court will grant Bryner’s Motion for Sum[757]*757mary Judgment and deny DuPont’s Motion for Summary Judgment.

I. BACKGROUND1

Bryner and his spouse, Lorraine Bryner (“Mrs. Bryner”), were covered by DuPont’s “Beneflex Accidental Death Insurance Plan” (the “Plan”). (PRU at 20-31.) Under the Plan terms, their lives were insured for any loss “directly related to the injuries from [an] accident.” (DUP at 174.) Further, the Plan excluded any death resulting from “sickness, disease or bodily infirmity except when a direct result of a covered accident.” (Id.) However, conspicuously absent from the Plan is any definition of a “covered accident.” Although Prudential is the insurer obligated to pay claims under the plan, DuPont serves as the “Plan Administrator” vested with “the discretionary right to determine eligibility for benefits ... and to construe the terms and conditions of [the] Plan.” (Id. at 194.) Prudential makes initial decisions on claims and reconsideration requests, but DuPont ultimately has full authority to review those decisions. (Id. at 175-76.)

For several years, Mrs. Bryner suffered from a number of medical conditions, including gout and renal disease, the latter of which led to a kidney transplant after numerous hospitalizations. (PRU at 211-225.) To treat her non-fatal gout, Mrs. Bryner’s physicians prescribed a standard dose of twice-daily colchicine, which she was instructed to increase to a dose of five or six tablets per day when necessary to control pain. (Id. 80-81.) She took such a heightened dose around April 5, 2004, and soon thereafter developed a fever, altered mental status, and leukopenia.2 (Id. at 215.)

After a weeklong hospitalization, Mrs. Bryner died on April 15,2004. (Id.) As her condition deteriorated, her physicians noted that she was experiencing multiple organ system failure, anoxic brain injury, and no cranial nerve reflexes. (Id.) Although Mrs. Bryner’s original death certificate identified the cause of death as “overwhelming sepsis,” the death certificate was revised to indicate a “possible colchicine overdose.” (Id. at 90.)

In December 2004, after considering the medical evidence, Bryner filed a claim for benefits under the terms of the Plan. (Id. at 79-80.) He based his claim on evidence that Mrs. Bryner’s “death was due to accidental colchicine poisoning following a severe gout attack.” (Id. at 79.) Prudential denied the claim initially and on reconsideration, noting that the hospital records failed to indicate a colchicine overdose. (Id. at 202-05, 277-79.)

In his appeal to Prudential, Bryner included additional evidence of colchicine poisoning, relying principally on the medical opinion of Jack Daniel, M.D. (“Dr. Daniel”), a pathologist. Based on his review of the medical records and experience as a former medical examiner, Dr. Daniel concluded “to a reasonable degree of medical certainty that the findings are entirely [758]*758consistent with the underlying and proximate cause of Mrs. Bryner’s death having been acute colchicine toxicity.” (PRU at 175.) Prudential submitted Dr. Daniel’s findings and the other medical evidence to its own Medical Director, Joyce Bachman, M.D. (“Dr. Bachman”). While acknowledging that “colchicine toxicity is consistent with the clinical picture” illustrated in Mrs. Bryner’s records, she concluded that death resulted from “a combination of factors.” (Id. at 97.) Relying on this conclusion, Prudential again denied the claim. (Id. at 203-04.)

Bryner then appealed Prudential’s decision to DuPont, which retains authority to overrule any decision made by Prudential. (DUP at 176.) Based on the same record submitted to Prudential, an independent panel at DuPont upheld denial of the claim. Rejecting Bryner’s assertion that colchicine toxicity was “the sole cause of death,” DuPont applied the exclusion for “sickness, disease or bodily infirmity except when as a direct result of a covered accident.” (Id. at 6.) In effect, DuPont relied on the existence of multiple causes of death to reject any contention that Mrs. Bryner’s death was “a direct result of a covered accident.” (Id.) Notably, DuPont did not indicate whether it would have denied benefits had it concluded that colchicine toxicity was, in fact, a direct cause of death.

On April 15, 2009, Bryner filed his first lawsuit in this Court challenging the decisions of Prudential and DuPont. Pursuant to a settlement agreement reached in that case, DuPont agreed to reconsider Bryner’s claim de novo, including consideration of the opinion of Brandon Wills, D.O. (“Dr. Wills”).3 Bryner had submitted his wife’s medical records to Dr. Wills soon after DuPont denied his appeal. In his report, Dr. Wills criticized several aspects of Dr. Bachman’s findings and disagreed with her conclusion. (Id. at 323-24.) From his review of the medical evidence, Dr. Wills concluded that colchicine alone was the cause of Mrs. Bryner’s death. (Id. at 323.)

In considering Dr. Wills’ opinion and Bryner’s final submission, DuPont obtained an independent evaluation from Vincent J. Zarro, Ph.D., M.D. (“Dr. Zarro”). Dr. Zarro agreed with Dr. Daniels’ findings, concluding that Mrs. Bryner’s death was triggered solely by a toxic dosage of colchicine. (Id. at 229.) And while Dr. Zarro indicates that the dosage taken is no longer recommended in any medical literature, he acknowledges that such dosage was considered appropriate during the relevant time frame. (Id.) Despite these findings, DuPont again denied the claim, concluding that death due to a prescribed course of medical treatment does not fall within the definition of a “covered accident.” In its final analysis, DuPont based its decision on the fact that Mrs. Bryner’s death “was the direct result of a deliberate action rather than a covered accident.” (Id. at 203.) Noting that the term “ ‘[accident’ is not defined in the Plan,” DuPont [759]*759concluded that “whether or not an ‘accident’ occurs depends on objective actions, not on the subjective expectations of the insured.” (Id.) This definition, however, is neither based on the text of the Plan, lexicography, nor clearly established law.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Bryner v. E.I. DuPont De Nemours & Co.
950 F. Supp. 2d 840 (E.D. Virginia, 2013)

Cite This Page — Counsel Stack

Bluebook (online)
914 F. Supp. 2d 755, 55 Employee Benefits Cas. (BNA) 1781, 2012 WL 6725634, 2012 U.S. Dist. LEXIS 182133, Counsel Stack Legal Research, https://law.counselstack.com/opinion/bryner-v-ei-dupont-de-nemours-co-vaed-2012.